PL1654353T3 - Nowotworowe linie komórkowe NM-F9 (DSM ACC2606) i NM-D4 (DSM ACC2605) oraz ich zastosowanie - Google Patents
Nowotworowe linie komórkowe NM-F9 (DSM ACC2606) i NM-D4 (DSM ACC2605) oraz ich zastosowanieInfo
- Publication number
- PL1654353T3 PL1654353T3 PL04764266T PL04764266T PL1654353T3 PL 1654353 T3 PL1654353 T3 PL 1654353T3 PL 04764266 T PL04764266 T PL 04764266T PL 04764266 T PL04764266 T PL 04764266T PL 1654353 T3 PL1654353 T3 PL 1654353T3
- Authority
- PL
- Poland
- Prior art keywords
- dsm
- threreof
- cell lines
- tumour cell
- acc2605
- Prior art date
Links
- 210000004881 tumor cell Anatomy 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0693—Tumour cells; Cancer cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5158—Antigen-pulsed cells, e.g. T-cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- Oncology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- General Engineering & Computer Science (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03018576 | 2003-08-18 | ||
PCT/EP2004/009281 WO2005017130A2 (en) | 2003-08-18 | 2004-08-18 | Tumour cell lines nm-f9 (dsm acc2606) and nm-d4 (dsm acc2605), uses thereof |
EP04764266.5A EP1654353B1 (en) | 2003-08-18 | 2004-08-18 | Tumour cell lines nm-f9 (dsm acc2606) and nm-d4 (dsm acc2605), uses threreof |
Publications (1)
Publication Number | Publication Date |
---|---|
PL1654353T3 true PL1654353T3 (pl) | 2013-11-29 |
Family
ID=34178385
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL04764266T PL1654353T3 (pl) | 2003-08-18 | 2004-08-18 | Nowotworowe linie komórkowe NM-F9 (DSM ACC2606) i NM-D4 (DSM ACC2605) oraz ich zastosowanie |
Country Status (9)
Country | Link |
---|---|
US (2) | US8017388B2 (pl) |
EP (1) | EP1654353B1 (pl) |
CY (1) | CY1114643T1 (pl) |
DK (1) | DK1654353T3 (pl) |
ES (1) | ES2425475T3 (pl) |
PL (1) | PL1654353T3 (pl) |
PT (1) | PT1654353E (pl) |
SI (1) | SI1654353T1 (pl) |
WO (1) | WO2005017130A2 (pl) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003260426A1 (en) * | 2002-08-16 | 2004-03-11 | Glycotope Gmbh | Process for the production of temperature-induced tumor cell lysates for use as immunogenic compounds |
EP1654353B1 (en) | 2003-08-18 | 2013-05-22 | Glycotope GmbH | Tumour cell lines nm-f9 (dsm acc2606) and nm-d4 (dsm acc2605), uses threreof |
US8609370B2 (en) | 2004-02-13 | 2013-12-17 | Glycotope Gmbh | Highly active glycoproteins-process conditions and an efficient method for their production |
EP1900750A1 (en) * | 2006-09-18 | 2008-03-19 | Glycotope Gmbh | Fully human high yield production system for improved antibodies |
ES2533964T5 (es) | 2006-09-10 | 2024-05-09 | Glycotope Gmbh | Uso de células humanas de origen leucémico mieloide para expresión de anticuerpos |
EP1911766A1 (en) * | 2006-10-13 | 2008-04-16 | Glycotope Gmbh | Use of human cells of myeloid leukaemia origin for expression of antibodies |
EP1920781B1 (en) | 2006-11-10 | 2015-03-04 | Glycotope GmbH | Compositions comprising a core-1 positive microorganism and their use for the treatment or prophylaxis of tumors |
EP2281844A1 (en) | 2009-07-31 | 2011-02-09 | Glycotope GmbH | MUC 1 antibodies |
TWI604850B (zh) * | 2009-10-05 | 2017-11-11 | 菲瑞茵國際中心股份有限公司 | 藥學製劑 |
EP2347769A1 (en) | 2010-01-20 | 2011-07-27 | Glycotope GmbH | Cancer stem cell markers and uses thereof |
US20130130317A1 (en) | 2010-08-02 | 2013-05-23 | Kyowa Hakko Kirin Co., Ltd | Method for producing substance |
EP2603528B1 (en) | 2010-08-10 | 2016-10-12 | Glycotope GmbH | Fab-glycosylated antibodies |
EP3147355B1 (en) | 2010-12-27 | 2020-07-22 | Kyowa Kirin Co., Ltd. | Method for preparing aqueous solution containing culture medium and chelating agent |
EP2748302B1 (en) | 2011-08-22 | 2018-08-15 | Glycotope GmbH | Microorganisms carrying a tumor antigen |
CN108588030B (zh) * | 2018-03-30 | 2020-07-14 | 四川迈克生物新材料技术有限公司 | 抗人IgM单克隆抗体、其杂交瘤细胞株及应用 |
JP2021524740A (ja) | 2018-05-18 | 2021-09-16 | グリコトープ ゲーエムベーハー | 抗muc1抗体 |
EP3875595A4 (en) | 2018-11-02 | 2022-07-13 | Kyowa Kirin Co., Ltd. | METHOD FOR PREPARING LIQUID CULTURE MEDIUM |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4931275A (en) | 1985-12-02 | 1990-06-05 | Yeda Research & Development Co., Ltd. | Anti-tumor vaccines and their preparation |
WO1994029469A2 (en) | 1993-06-07 | 1994-12-22 | Vical Incorporated | Plasmids suitable for gene therapy |
US5997873A (en) | 1994-01-13 | 1999-12-07 | Mount Sinai School Of Medicine Of The City University Of New York | Method of preparation of heat shock protein 70-peptide complexes |
US5961979A (en) | 1994-03-16 | 1999-10-05 | Mount Sinai School Of Medicine Of The City University Of New York | Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens |
AU723325B2 (en) | 1995-06-23 | 2000-08-24 | President And Fellows Of Harvard College | Transcriptional regulation of genes encoding vascular endothelial growth factor receptors |
EP0906444A1 (de) | 1996-04-19 | 1999-04-07 | Gabriele Pecher | Gentransfizierte humane dendritische zellen, ihre herstellung und ihre verwendung, bevorzugt als vakzine |
CA2309766C (en) * | 1997-11-20 | 2008-09-30 | Vical Incorporated | Treatment of cancer using cytokine-expressing polynucleotides and compositions therefor |
US5948646A (en) | 1997-12-11 | 1999-09-07 | Fordham University | Methods for preparation of vaccines against cancer comprising heat shock protein-peptide complexes |
WO2001023421A2 (en) | 1999-09-30 | 2001-04-05 | Corixa Corporation | Stress protein compositions and methods for prevention and treatment of cancer and infectious disease |
DE10139428A1 (de) | 2001-08-17 | 2003-03-27 | Nemod Immuntherapie Ag | Herstellung und Verwendung von humanen CD124 und CD116 positiven Tumorzelllinien zur Herstellung von allogenen oder semi-allogenen Immuntherapeutika |
AU2003266236A1 (en) * | 2002-07-22 | 2004-02-09 | Nemod Immuntherapie Ag | Method for the production of an immunostimulating mucin (muc1) |
AU2003260426A1 (en) | 2002-08-16 | 2004-03-11 | Glycotope Gmbh | Process for the production of temperature-induced tumor cell lysates for use as immunogenic compounds |
EP1654353B1 (en) | 2003-08-18 | 2013-05-22 | Glycotope GmbH | Tumour cell lines nm-f9 (dsm acc2606) and nm-d4 (dsm acc2605), uses threreof |
-
2004
- 2004-08-18 EP EP04764266.5A patent/EP1654353B1/en active Active
- 2004-08-18 PL PL04764266T patent/PL1654353T3/pl unknown
- 2004-08-18 DK DK04764266.5T patent/DK1654353T3/da active
- 2004-08-18 SI SI200432070T patent/SI1654353T1/sl unknown
- 2004-08-18 US US10/568,098 patent/US8017388B2/en active Active
- 2004-08-18 PT PT47642665T patent/PT1654353E/pt unknown
- 2004-08-18 ES ES04764266T patent/ES2425475T3/es active Active
- 2004-08-18 WO PCT/EP2004/009281 patent/WO2005017130A2/en active Application Filing
-
2011
- 2011-08-11 US US13/208,253 patent/US8283161B2/en active Active
-
2013
- 2013-08-12 CY CY20131100688T patent/CY1114643T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP1654353B1 (en) | 2013-05-22 |
DK1654353T3 (da) | 2013-08-26 |
US20060292129A1 (en) | 2006-12-28 |
SI1654353T1 (sl) | 2013-09-30 |
US8017388B2 (en) | 2011-09-13 |
CY1114643T1 (el) | 2016-10-05 |
WO2005017130A2 (en) | 2005-02-24 |
WO2005017130A3 (en) | 2005-06-23 |
PT1654353E (pt) | 2013-08-23 |
US8283161B2 (en) | 2012-10-09 |
ES2425475T3 (es) | 2013-10-15 |
EP1654353A2 (en) | 2006-05-10 |
US20110319590A1 (en) | 2011-12-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AP2280A (en) | Compositions and methods for increasing telomeraseactivity. | |
AU2003262747A8 (en) | Compounds, compositions, and methods | |
EP1503993A4 (en) | COMPOUNDS, METHODS AND COMPOSITIONS | |
AU2003236527A8 (en) | Compounds, compositions, and methods | |
AU2003265242A8 (en) | Compounds, compositions, and methods | |
HK1070656A1 (en) | Compounds, compositions, and methods | |
AU2003270015A8 (en) | Compounds, compositions, and methods | |
MXPA03009132A (es) | Alquilhidroxamatos triciclicos, su preparacion y su uso como inhibidores de la proliferacion de celulas. | |
GB0318099D0 (en) | Mixing devices,systems and methods | |
AU2003299612A8 (en) | Compounds, compositions and methods | |
SI1654353T1 (sl) | Tumorski celični liniji NM-F9 (DSM ACC2606) in NM-D4 (DSM ACC2605), njihove uporabe | |
IL167936A0 (en) | Compounds, compositions,and methods | |
EP1705740A4 (en) | FUEL FOR FUEL CELL, FUEL CELL AND USE THEREOF | |
AU2003290507A8 (en) | Compounds, compositions and methods | |
AU2003277079A8 (en) | Compounds, compositions, and methods | |
GB0207205D0 (en) | Polyurethane dispersion, manufacture and uses | |
IL177759A0 (en) | Cospeptin, cosmedin and their uses | |
AU2003267169A8 (en) | Compounds, compositions and methods | |
AU2003300031A8 (en) | Compounds, compositions, and methods | |
AP2006003512A0 (en) | Woos treating formulation. | |
AU2003237209A1 (en) | In situ reactor | |
GB0305089D0 (en) | Composition, use and process | |
EP1660088A4 (en) | PYRIDOMORPHINANES, PYRIDAZINOMORPHINANES AND USE THEREOF | |
GB0229445D0 (en) | Process,composition and use | |
GB0212528D0 (en) | Dispersion |